C. Sarries

发表

Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin-treated advanced non-small-cell lung cancer patients.

R. Rosell, J. Sánchez, C. Camps, 2003, Clinical lung cancer.

O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme.

Y. Roussos, C. Balañà, A. Ariza, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

O 6-methyl-guanine-DNA methyltransferase Methylation in Serum and Tumor DNA Predicts Response to 1 , 3-Bis ( 2-Chloroethyl )-1-Nitrosourea but not to Temozolamide Plus Cisplatin in Glioblastoma Multiforme 1

Y. Roussos, C. Balañà, A. Ariza, 2003 .

Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancer.

Pedro Mendez, Jose Luis Mate, Rafael Rosell, 2005, Lung cancer.

Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer.

G. Scagliotti, R. Rosell, M. Taron, 2002, Pharmacogenomics.

Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients.

R. Rosell, M. Taron, M. Margelí, 2003, Cancer letters.

Serum DNA as a tool for cancer patient management.

C. Balañà, M. Taron, J. Ramírez, 2003, Roczniki Akademii Medycznej w Bialymstoku.

Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer.

M. Taron, M. Sánchez-Ronco, J. Sánchez, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Nucleotide excision repair pathways involved in Cisplatin resistance in non-small-cell lung cancer.

G. Scagliotti, R. Rosell, A. Barnadas, 2003, Cancer control : journal of the Moffitt Cancer Center.

Effect of the methylenetetrahydrofolate reductase C677T polymorphism on patients with cisplatin/gemcitabine-treated stage IV non-small-cell lung cancer.

R. Rosell, M. Taron, M. Sánchez-Ronco, 2004, Clinical lung cancer.

β-Tubulin mutational analysis: tantalizing findings

R. Rosell, M. Taron, C. Sarries, 2002 .

Combined DNA repair gene single nucleotide polymorphisms (SNPs) in gemcitabine (gem)/cisplatin (cis)-treated non-small-cell lung cancer (NSCLC) patients (p).

R. Rosell, M. Taron, M. Sánchez-Ronco, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme.

Y. Roussos, C. Balañà, A. Ariza, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.